Xiaoxi Yao, Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues randomly assigned 120 primary care teams, including 358 clinicians, to intervention (access to AI results from the low ejection fraction algorithm developed by Mayo and licensed to Anumana Inc.; 181 clinicians) or control (usual care; 177 clinicians) in a pragmatic trial at 45 clinics and hospitals. More echocardiograms were obtained for patients with positive results by clinicians in the intervention group (49.6 versus 38.1 percent), but echocardiogram use was similar in the overall cohort (19.2 versus 18.2 percent). The diagnosis of low EF was increased with the intervention in the overall cohort (2.1 versus 1.6 percent; odds ratio, 1.32) and among patients with positive results (19.5 versus 14.5 percent; odds ratio, 1.43). "The AI intervention increased the diagnosis of low ejection fraction overall by 32 percent relative to usual care.
Jun-4-2021, 20:52:13 GMT